Laboratory Equipment and Instruments

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Bio-Rad Laboratories’ EconoFit Column Packs provide resin screening for customers developing protein purification workflows.

Thermo Fisher Scientific’s QualTrak is tailored for biologics development.

As the development of increasingly complex biologics grows, more robust bioassays are required to accurately characterize these molecules.

Analytical techniques for validating cleaning methods must evolve to match the pace of an increasingly complex manufacturing landscape for new therapeutics.

Scientific Laboratory Supplies’ acquisition of C&M will bolster the company’s scientific calibration, maintenance, and validation offerings.

Agilent will work with Quest Diagnostics to distribute the ctDx FIRST test.

It’s crucial to consider the optimal handling systems for cleanroom and other lab environments.

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.

The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

PK/PD studies are a crucial tool in the successful development of biologics.

The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.

The R&D analytical solutions will consist of analytical lab services that use USP’s in-house scientific expertise and state-of-the-art facilities at the USP Advanced Manufacturing Technology Lab in Richmond and the USP headquarters facility in Rockville, Md.

One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.

Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.

Replacing a step in sample preparation with an automated approach improves both method precision and productivity.

Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.

With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.

OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.